Angiotensin receptors: Signaling, vascular pathophysiology, and interactions with ceramide

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 281, Issue 6 50-6, 2001, Pages

  Berry, C ^a   Touyz, R ^a   Dominiczak, A F ^b   Webb, R C ^b,d   Johns, D G ^c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin receptor antagonist; Renin angiotensin system; Second messenger

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ARACHIDONIC ACID; BRADYKININ; CALCIUM ION; CERAMIDE; CYTOKINE RECEPTOR; LIPID; NITRIC OXIDE; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE; RECEPTOR SUBTYPE; VASOACTIVE AGENT;

CELL DEATH; HYPERTENSION; HYPERTROPHY; ISCHEMIC HEART DISEASE; NATRIURESIS; PATHOPHYSIOLOGY; PLEIOTROPY; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; SODIUM RETENTION; VASCULAR DISEASE; VASOCONSTRICTION; VASODILATATION; WATER RETENTION;

EID: 0035665449     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.281.6.h2337     Document Type: Review

References (343)

1. Regulation of vascular angiotensin I receptors in the rat during altered sodium intake
2. 2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth
3. Angiotensin increases inositol trisphosphate and calcium in vascular smooth muscle
4. 1 receptor
5. 1 receptor
6. 2 receptors
7. 1 receptors
8. Angiotensin II receptors
9. Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole
10. 1-receptor subtype in failing human ventricular myocardium
11. Effectors for the Rho GTPases
12. 1 receptor antagonist in hypertensive rats
13. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases
14. 2
15. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase
16. c-src expression
17. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques
18. + exchange in cultured vascular smooth muscle cells: Evidence for protein kinase C-dependent and -independent pathways
19. Angiotensin II signal transduction in vascular smooth muscle: Role of tyrosine kinases
20. Inositol trisphosphate and diacylglycerol: Two interacting second messengers
21. Inositol phosphates and cell signaling
22. Angiotensin II stimulated superoxide production in human arteries
23. An investigation into the sources of superoxide production in human blood vessels: Angiotensin II increases superoxide production in human internal mammary arteries
24. Phospholipase D and cell signaling
25. A role for phospholipase D in control of mitogenesis
26. Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: Evidence for an endothelin-mediated mechanism
27. Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor
28. Hypertension and atherosclerosis: Cause and effect, or two effects with one unknown cause
29. 2 and signal transduction
30. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy
31. 2 receptors do not interact with guanine nucleotide binding proteins
32. Angiotensin II stimulates protein tyrosine phosphatase activity through a G protein-independent mechanism
33. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone
34. fak accompanies cell adhesion to extracellular matrix: A role in cytoskeletal assembly
35. Effects of losartan on angiotensin and bradykinin peptides and angiotensinconverting enzyme
36. Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy
37. 1A) ANG receptor
38. Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function
39. Identification and characterization of a new angiotensin II receptor subtype in differentiated neuro-2A cells
40. Ceramidecoated balloon catheters limit neointimal hyperplasia after stretch injury in carotid arteries
41. Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase
42. Angiotensin II receptors induce tyrosine dephosphorylation in rat fetal membranes
43. Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation
44. Inhibition by cAMP of rasdependent activation of raf
45. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product
46. Binding characteristics and vascular effects of various angiotensin II antagonists
47. Genetic analysis of the human type-1 angiotensin II receptor
48. Local renin-angiotensin systems
49. STATs and gene regulation
50. International Union of Pharmacology XXIII: The angiotensin II receptors
51. Proposed update of angiotensin receptor nomenclature
52. Does blockade of angiotensin II receptors offer clinical benefits over inhibition of angiotensinconverting enzyme?
53. 2 superfamily of signal transduction enzymes
54. Deglycosylation and fragmentation of purified rat liver angiotensin II receptor: Application to the mapping of hormone-binding domains
55. Phosphatidic acid: A potential signal transducer for cardiac hypertrophy
56. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation
57. Angiotensin induces apoptosis of human endothelial cells
58. Ceramide activates heterotrimeric protein phosphatase-2a
59. Purification and properties of angiotensin-converting enzyme from hog lung
60. Regulation of cytosolic calcium by angiotensins in vascular smooth muscle
61. G-protein and tyrosine kinase receptor cross-talk in rat aortic smooth muscle cells: Thrombin- and angiotensin II-induced tyrosine phosphorylation of insulin receptor substrate-1 and insulin-like growth factor 1 receptor
62. 2) binding sites in R3T3 cells
63. Angiotensin induces 3CH134, a protein-tyrosine phosphatase, in vascular smooth muscle cells
64. Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells
65. 2-mediated activation of mitogen-activated protein kinase by angiotensin II
66. Tissue renin-angiotensin system - Physiologic and pharmacologic implications: Introduction
67. Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase
68. Epidermal growth factor receptor is indispensable for c-Fos expression and protein synthesis by angiotensin II
69. 411 in vascular smooth muscle cells: Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt
70. 2+/calmodulin-sensitive tyrosine kinase
71. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells
72. Cross-talk between receptormediated phospholipase C-ß and D via protein kinase C as intracellular signal possibly leading to hypertrophy in serumfree cultured cardiomyocytes
73. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice
74. Signaling by tyrosine kinases
75. Counterregulatory actions of angiotensin-(1-7)
76. Tumor necrosis factor-α (TNF) and prostanoids are involved in angiotensin II
77. 2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes
78. Growth factors and mitogen-activated protein kinases
79. Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II
80. PYK2/CAK-ß represents a redox-sensitive tyrosine kinase in vascular smooth muscle cells
81. Role of calcium and protein kinase C in the activation of phospholipase D by angiotensin II in vascular smooth muscle cells
82. 2 to the nucleus in vascular smooth muscle cells
83. Angiotensin converting enzyme inhibitors suppress production of tumor necrosis factor-α in vitro and in vivo
84. The angiotensin II type 2 receptor: An enigma with multiple variations
85. 2 receptor stimulation induces generation of ceramides in PC 12W cells
86. 1 receptor antagonists on angiotensin II-induced tone in human isolated subcutaneous resistance arteries
87. Role of p70 S6 protein kinase in angiotensin II-induced protein synthesis in vascular smooth muscle cells
88. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism
89. Phospholipase D: A novel major player in signal transduction
90. Growth-dependent induction of angiotensin II type 2 receptor in rat mesangial cells
91. Reperfusion injury induces apoptosis in rabbit cardiomyocytes
92. Angiotensin II-induced inositol phosphate generation is mediated through tyrosine kinase pathways in cardiomyocytes
93. Focal adhesion kinase is involved in angiotensin II-mediated protein synthesis in cultured vascular smooth muscle cells
94. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
95. Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells
96. NAD(P)H oxidase: Role in cardiovascular biology and disease
97. Angiotensin II stimulation of vascular smooth muscle cells: Secondary signaling mechanisms
98. Angiotensin II signaling in vascular smooth muscle: New concepts
99. Focal adhesion kinase in integrin signaling
100. Signal transduction G proteins and small GTPases: Distant relatives keep in touch
101. 1 expression in vascular smooth muscle cells
102. The many faces of G protein signaling
103. The sphingomyelin cycle and the second messenger function of ceramide
104. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation
105. Sphingolipid breakdown products: Antiproliferative and tumor-suppressor lipids
106. Functional reconstitution of the angiotensin II type 2 receptor and Gi activation
107. Antagonistic actions of angiotensin II type-1 and -2 receptors on apoptosis in cultured neonatal rat ventricular myocytes
108. 2 angiotensin receptor gene expression in human heart failure
109. Signaling pathways in cardiac myocyte hypertrophy
110. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice
111. Rapid activation of neutral sphingomyelinase by hypoxiareoxygenation of cardiac myocytes
112. Involvement of Rho GTPases in the transcriptional inhibition of preproendothelin-1 gene expression by simvastatin in vascular endothelial cells
113. 1 receptor
114. Tyrosine kinase pathways and the regulation of smooth muscle contractility
115. Pathways for angiotensin II generation in intact human tissue: Evidence from comparative pharmacological interruption of the renin system
116. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system
117. 2 receptors, regulates STAT activation by negative cross talk
118. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis
119. 2 receptors in cell growth
120. Integrin signaling and cell growth control
121. Angiotensin II type-2 receptor-mediated stimulation of protein phosphatase 2A in rat hypothalamic/brainstem neuronal cocultures
122. Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin type 2 receptors
123. Molecular mechanisms of angiotensin II receptor internalization
124. 1 angiotensin receptor
125. Multiple growth factors modulate messenger RNA expression of angiotensin II type-2 receptor in R3T3 cells
126. Effects on blood pressure and exploratory behavior of mice lacking angiotensin II type-2 receptor
127. Molecular biology and signaling of angiotensin receptors: An overview
128. Cloning, expression and regulation of angiotensin II receptors
129. The tissue renin-angiotensin system in cardiovascular disease
130. Signal transduction by the c-Jun N-terminal kinase (JNK): From inflammation to development
131. Oxidant signaling in vascular cell growth, death, and survival
132. Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells
133. G protein-coupled receptor kinase 5 in cultured vascular smooth muscle cells and rat aorta: Regulation by angiotensin II and hypertension
134. Identification of 2 subtypes in the rat type-1 angiotensin II receptor
135. 2-dependent signaling in rabbit proximal tubular epithelial cells
136. 2-receptor activation, bradykinin and prostaglandins in pigs
137. 1 isoforms to bind the angiotensinogen gene acute phase response element: A stimulus-specific pathway for NF-κB activation
138. Characterization of IκB kinases: IκB-α is not phosphorylated by Raf-1 or protein kinase C isozymes, but is a casein kinase II substrate
139. Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine
140. 2 is necessary for tumor necrosis factor-α-induced ceramide generation in L929 cells
141. ras in renal proximal tubular cells via the tyrosine kinase-Shc-Grb2-Sos pathway
142. Regulation of jejunal sodium and water absorption by angiotensin subtype receptors
143. Altered ceramide signaling in stroke-prone spontaneously hypertensive rat vascular smooth muscle cells: A possible mechanism for augmented cell proliferation
144. Ceramide: A novel cell signaling mechanism for vasodilation
145. 2)-dependent ceramide signaling in the vasculature
146. Evidence that ceramide selectively inhibits protein kinase C-a translocation and modulates bradykinin activation of phospholipase D
147. Agonist-induced phosphorylation of the vascular type-1 angiotensin II receptor
148. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition
149. + currents involves an inhibitory GTP-binding protein
150. The beginning of the end: IκB kinase (IκK) and NF-κB activation
151. γi phosphorylation on tyrosine residues 783 and 1254
152. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor-α and interferon-γ-specific role in cell differentiation
153. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal disease
154. Angiotensin II activates the proinflammatory transcription factor nuclear factor-κB in human monocytes
155. Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats
156. Raf-1 activates MAP kinase kinase
157. Phosphatidylcholine is a major source of phosphatidic acid and diacylglycerol in angiotensin II-stimulated vascular smooth muscle cells
158. Targeting Rho in cardiovascular disease
159. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension
160. 2 receptor gene highly expressed in fetal tissues
161. 2 angiotensin II receptor from human myometrium
162. Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells
163. Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in aortic smooth muscle cells
164. Ceramide inactivates cellular protein kinase C-α
165. Signalling through phosphoinositide 3-kinases: The lipids take centre stage
166. Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis
167. Chronic blockade of ATP-subtype receptors prevents the effect of angiotensin II on the rat vascular structure
168. 1 receptor and PKC activation
169. 11) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation
170. Effect of ceramide on K-Ca channel activity and vascular tone in coronary arteries
171. Differential regulation of insulinstimulated tyrosine phosphorylation of IRS-1 and SHC by wortmannin in intact cells
172. Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells
173. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: Role of kinins and angiotensin II type 2 receptors
174. Subtype-2 of angiotensin-II receptors controls pressure natriuresis in rats
175. Angiotensin II stimulates the release of phospholipid-derived second messengers through multiple receptor subtypes in heart cells
176. 2-receptor subtypes in hypertrophied rat hearts
177. Regulation of tyrosine kinase cascades by G protein-coupled receptors
178. 2-adrenergic receptor Src protein kinase complexes
179. Effect of interactions between nitric oxide and angiotensin II on pressure natriuresis
180. Angiotensin II receptor subtypes in the skeletal muscle vasculature of patients with severe congestive heart failure
181. γ1 in vascular smooth muscle cells
182. γ1 in rat aortic smooth muscle cells
183. Role of Janus kinase signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation
184. 1 receptor
185. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-related kinase activation
186. 1 receptormediated pressor and chronotropic effects
187. Characterization of a ceramide-activated protein kinase: Stimulation by tumor necrosis factor-α
188. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases
189. Sphingolipidsthe enigmatic lipid class: Biochemistry, physiology, and pathophysiology
190. Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells
191. Mitogen-activated protein kinase and proliferation of human vascular smooth muscle cells
192. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs
193. Rhodopsin-family receptors associate with small G proteins to activate phospholipase D
194. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells
195. Selective inhibition of the renal angiotensin type 2 receptor increases blood pressure in conscious rats
196. Angiotensinogen: Molecular biology, biochemistry and physiology
197. From Vanadis to Atropos: Vanadium compounds as pharmacological tools in cell death signalling
198. Stimulation of two vascular smooth muscle-derived cell lines by angiotensin II: Differential second-messenger responses leading to mitogenesis
199. Expression cloning of type-2 angiotensin II receptor reveals a unique class of 7-transmembrane receptors
200. NF-κB inhibition ameliorates angiotensin II-induced inflammatory damage in rats
201. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure
202. 2+/calmodulin-dependent transactivation of epidermal growth factor receptor
203. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
204. 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells
205. Mechanism of CaM kinase II (CaMKII) mediated MAP kinase (MAPK) activation by norepinephrine (NE) in vascular smooth muscle cells (VSMC): Involvement of cytochrome P-450 (CYP-450) and lipoxygenase (LO) metabolites of arachidonic acid (AA)
206. 2 receptor: Searching for signal transduction pathways and physiological function
207. 1 receptor: Gain-of-function study using gene transfer
208. Cas is involved in actin organization in osteoclasts
209. Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo
210. The role of eicosanoids in angiotensin-dependent hypertension
211. The p38 MAP kinase pathway and its biological function
212. cas, a Src homology 3-containing molecule having multiple Src homology 2-binding motifs
213. Angiotensin II transduces its signal to focal adhesions via angiotensin II type-1 receptors in vascular smooth muscle cells
214. 2 receptor requires a tyrosine protein kinase
215. ANG II stimulates endothelial nitric oxide synthase expression in bovine pulmonary artery endothelium
216. Phosphorylation of the type 1A angiotensin II receptor by G protein-coupled receptor kinases and protein kinase C
217. Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells
218. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats
219. Renal oxygenases: Differential contribution to vasoconstriction induced by ET-1 and ANG II
220. 2) receptor protein in rat kidney
221. phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts
222. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin II
223. Src family protein tyrosine kinases: Cooperating with growth factor and adhesion signaling pathways
224. 1 receptor is tyrosine and serine phosphorylated and can serve as a substrate for the Src family of tyrosine kinases
225. ACE- and non-ACE-dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease
226. Levels of angiotensin and molecular biology of the tissue renin-angiotensin systems
227. 2 receptor-mediated P-selectin upregulation
228. Focal adhesion kinase is abundant in developing blood vessels and elevation of its phosphotyrosine content in vascular smooth muscle cells is a rapid response to angiotensin II
229. 1 receptors in endothelial cells
230. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-κB activation induced by intracellular oxidative stress
231. S6K
232. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: Contribution to alterations of vasomotor tone
233. Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinases and activates Ras and extracellular signal-related protein kinase group of mitogen-activated protein kinases
234. Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells
235. Angiotensin receptor type 1 mRNA in human right ventricular endomyocardial biopsies: Downregulation in heart failure
236. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts
237. Regulation of inositol phospholipid specific phospholipase C isozymes
238. Mitogen-activated protein kinase pathways
239. Angiotensin II signal-transduction pathways in the cardiovascular system
240. Convergent signaling in the action of integrins, neuropeptides, growth factors and oncogenes
241. Angiotensin III increases MCP-1 and activates NF-κB and AP-1 in cultured mesangial and mononuclear cells
242. 2 in vascular smooth muscle cells: Molecular mechanisms
243. Calcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle
244. Versatility of the angiotensin II type 1 receptor
245. Cytokine actions of angiotensin II
246. Signal-transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro: Roles of phospholipid-derived second messengers
247. ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes
248. Structural analysis and regulation of angiotensin II receptors
249. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type 1 receptor
250. Modulation of the calcium sensitivity of the smooth muscle contractile apparatus: Molecular mechanisms, pharmacological and pathophysiological implications
251. Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells
252. 2+, and protein kinase C
253. The angiotensin II-dependent association of Jak2 and c-Src requires the N-terminus of Jak2 and the SH2 domain of c-Src
254. src
255. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction
256. c-src
257. Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2 mitogen-activated protein kinase: Summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events
258. Angiotensin II stimulates p21-activated kinase in vascular smooth muscle cells: Role in activation of JNK
259. No vasoactive role of the angiotensin II type 2 receptor in normotensive Wistar rats
260. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax
261. 2+-channel current in vascular smooth muscle cells is inhibited by lavendustin-A and LY-294002
262. Cellular and molecular dissection of reperfusion injury: ROS within and without
263. 2) is essential for the development of cardiac hypertrophy by pressure overload
264. Lipid mediator networks in cell signaling: Update and impact of cytokines
265. Angiotensin II type 2 receptor mRNA expression in the developing cardiopulmonary system of the rat
266. 2) receptor messenger RNA in the rat
267. Sphingolipids: Their role in intracellular signaling and renal growth
268. 2 production in conscious rats
269. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats
270. 2 receptor in a renal wrap hypertension model
271. Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats
272. 1R) blockade mediates a renal bradykinin (BK)-nitric oxide (NO) cascade
273. 2) angiotensin receptor
274. Renin-angiotensin system modulates renal bradykinin production
275. Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor
276. Biochemistry and kinetics of the renin-angiotensin system
277. Sphingomyelinases
278. Mechanical strain increases collagen I mRNA expression in cultured human vascular smooth muscle cells via an angiotensin II-dependent pathway
279. Selective inhibition of angiotensin II-mediated vasoconstriction by lipoxygenase blockade
280. 2 receptor mediates inhibition of cell proliferation in coronary endothelial cells
281. 2+ influx
282. Redox regulation of signal transduction in cardiac and smooth muscle
283. Discovery of a distinct binding site for angiotensin II-(3-8), a putative angiotensin IV receptor
284. Angiotensin II stimulates mitogen-activated protein kinases and protein synthesis by a Ras-independent pathway in vascular smooth muscle cells
285. Cas and c-Crk II by ANG II in vascular smooth muscle cells
286. Activation of Akt protein kinase B after stimulation with angiotensin II in vascular smooth muscle cells
287. Characterization of chymase from human vascular tissues
288. q class of G proteins
289. Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER pathway
290. Cellular functions regulated by Src family kinases
291. 1) receptor function
292. 1A) receptor carboxyl terminus: A role in receptor endocytosis
293. 2 receptors in angiotensin II stimulation of small mesenteric arteries in young SHR
294. Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries
295. 1 receptors in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats
296. MEK inhibition attenuates ANG II-induced signaling and contraction in SHR vascular smooth muscle cells
297. Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways
298. Role of calcium influx and intracellular calcium stores in angiotensin II-mediated calcium hyperresponsiveness in smooth muscle from spontaneously hypertensive rats
299. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells
300. 2+ signaling in human vascular smooth muscle cells
301. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation
302. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression
303. 2) receptor in R3T3 cells
304. The angiotensin type 2 receptor: Variations on an enigmatic theme
305. Chymase-dependent angiotensin II-forming system in humans
306. p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II: Role in vascular smooth muscle cell hypertrophy
307. Angiotensin II receptor coupling to phospholipase D is mediated by the βγ-subunits of heterotrimeric G proteins in vascular smooth muscle cells
308. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells
309. phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells
310. Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats
311. + exchange kinetics and its activation by angiotensin II
312. Blockade of the renin angiotensin system in heart failure: The potential place of angiotensin II receptor blockers
313. Angiotensin II regulates the expression of plasminogen-activator inhibitor-1 in cultured endothelial cells: A potential link between the reninangiotensin system and thrombosis
314. Angiotensin II-induced tyrosine phosphorylation of signal transducers and activators of transcription 1 is regulated by Janus-activated kinase 2 and Fyn kinases and mitogen-activated protein kinase phosphatase 1
315. phox and reactive oxygen species
316. 2 receptors in the skin of rats during experimental wound healing
317. Role of S6 phosphorylation and S6 kinase in cell growth
318. 1-adrenergic stimulation of Na-H exchange in cardiac myocytes
319. Intracellular mechanisms involved in the regulation of vascular smooth muscle tone
320. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide
321. Paracrine role of adventitial superoxide anion in spontaneous tone in the isolated rat aorta in angiotensin II-induced hypertension
322. Renal expression of angiotensin II type 2 receptor protein in man
323. 2 receptor protein in rats with angiotensin-dependent hypertension
324. Ceramide activates the stress-activated protein kinases
325. 2 receptors in the normal and failing human heart
326. Vasoconstrictor prostaglandins and angiotensin-dependent renovascular hypertension
327. Stimulated mitogen-activated protein kinase is necessary but not sufficient for the mitogenic response to angiotensin II: A role for phospholipase D
328. Structure and function of phosphoinositide-3-kinases
329. Central role of the MAPK pathway in ANG II-mediated DNA synthesis and migration in rat vascular smooth muscle cells
330. 2+ and cardiac contractile force
331. 2 receptor and vascular smooth muscle cell differentiation in vascular development
332. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: An in vitro gene transfer study
333. Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts
334. Characterisation of angiotensin II receptors in isolated human subcutaneous resistance arteries
335. Activation of a novel calcium-dependent protein tyrosine kinase: Correlation with c-Jun N-terminal kinase but not mitogen-activated protein kinase activation
336. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
337. 2 in angiotensin II-induced vascular hypertrophy
338. Arachidonic acid metabolites mediate angiotensin II-induced NADH/NADPH oxidase activity and hypertrophy in vascular smooth muscle cells
339. 3 in the rat fetus
340. Differential regulation of Pyk2 and focal adhesion kinase (FAK): The C-terminal domain of FAK confers response to cell adhesion
341. 2 and arachidonic acid
342. 4 receptors
343. Cell type-specific angiotensin II-evoked signal transduction pathways: Critical roles of Gβγ subunit, Src family, and Ras in cardiac fibroblasts